Wyss Institute Research Collaboration Awarded ARPA-H Agreement to Develop Disease-Agnostic Immunotherapeutic RNA Platform
15 juil. 2024 11h00 HE
|
Wyss Institute at Harvard University
Boston, July 15, 2024 (GLOBE NEWSWIRE) -- With the award for up to $27M from the Advanced Research Projects Agency for Health (ARPA-H), a collaborative research project at the Wyss Institute for...
Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
15 mai 2024 07h00 HE
|
Wyss Institute at Harvard University
Boston, MA, May 15, 2024 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Circe, a startup developed at the Institute and spun...
Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics
08 avr. 2024 11h00 HE
|
Wyss Institute at Harvard University
Boston, MA, April 08, 2024 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that the VC firm’s affiliate...
Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
23 mai 2023 09h00 HE
|
Wyss Institute at Harvard University
Boston, MA, May 23, 2023 (GLOBE NEWSWIRE) -- Collaborative Fund and the Wyss Institute for Biologically Inspired Engineering at Harvard University are joining forces to launch a research and...
Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
04 avr. 2023 09h00 HE
|
Wyss Institute at Harvard University
Boston, April 04, 2023 (GLOBE NEWSWIRE) -- (BOSTON, INSERT DATE) —The Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston Children’s Hospital, and Northpond Labs, the...
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
21 févr. 2023 08h00 HE
|
Wyss Institute at Harvard University
BOSTON, MA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied....
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
19 déc. 2022 10h14 HE
|
Wyss Institute at Harvard University
Boston, Dec. 19, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and EnPlusOne Biosciences (EnPlusOne Bio) announced that...
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
17 oct. 2022 11h00 HE
|
Wyss Institute at Harvard University
Boston, Oct. 17, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sherlock Biosciences Inc., announced that Sherlock has...
Unravel Biosciences licenses Wyss Institute platform technology from Harvard and Tufts University to decode, model, and treat complex diseases
27 sept. 2022 13h38 HE
|
Wyss Institute at Harvard University
Boston, MA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Today, Unravel Biosciences and the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that Unravel has licensed a...
Wyss Institute at Harvard University launches SPEAR Bio to empower disease research, patient care, and drug development with its small-sample, ultrasensitive, protein-detection technology
23 août 2022 11h45 HE
|
Wyss Institute at Harvard University
Wyss Institute at Harvard University, Aug. 23, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced...